Peter C. Farrell is the founder and former CEO of ResMed Inc., a leading company in the healthcare sector focused on developing solutions for people with sleep apnea and chronic obstructive pulmonary disease. Under his leadership from 1989 until January...
Peter C. Farrell is the founder and former CEO of ResMed Inc., a leading company in the healthcare sector focused on developing solutions for people with sleep apnea and chronic obstructive pulmonary disease. Under his leadership from 1989 until January 2023, ResMed has grown significantly, becoming a key player in the healthcare technology industry. He transitioned to the role of chair emeritus after appointing Michael ‘Mick’ Farrell as the new chair of the board, highlighting his lasting impact on the company. Interestingly, Peter has consistently driven ResMed’s performance metrics including revenue growth and operational efficiency, demonstrating a commitment to aligning executive compensation with company success. His compensation has remained steady, peaking at $2.2 million in 2017, reflecting the company's ups and downs. Furthermore, Peter’s insider trading activity shows fluctuations in his wealth tied to ResMed, with stock values reaching over $268 million in late 2020. This indicates a significant stake in the company and suggests a strong belief in its future. Peter is a recognized figure in the healthcare industry, known for his strategic guidance and vision, and remains influential as a board member after a remarkable leadership tenure.